Medical/Pharmaceuticals
Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse
REYKJAVÍK, Iceland, Nov. 26, 2021 /PRNewswire/ -- Aztiq
Starpharma releases positive DEP® phase 2 interim results in prostate cancer
MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel. The company showed that 100% of evaluable patients with (Stage IV) metastatic prostat...
Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary
SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC)
celebrates the 122nd anniversary of its premium red ginseng brand,
CheongKwanJang.
Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary
SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC)
celebrates the 122nd anniversary of its premium red ginseng brand,
CheongKwanJang.
Antengene Included in the MSCI Global Small Cap Indexes - MSCI China Index Constituent Stocks
SHANGHAI and HONG KONG, Nov. 26, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...
IASO Biotheraputics' CT120 Granted Orphan Drug Designation by the U.S. FDA
SAN JOSE, Calif., NANJING, China and SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on discovering, developing, and manufacturing innovative medicine announcedon Oct 26, 2021 that the Office of Orphan Products Developme...
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, andAsia-based global healthcare investors Tybourne Capital Management and NSG Ventures - Following the most recent strategic investment of $26 million from Guardant Heal...
Biotron Drug Effective Against COVID-19 In Animals
* BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. * BIT225 protected against severe disease, indicated by the significant prevention of body weight loss in animals treated with BIT225 compared to non-treated controls. ...
How CIIE offers a window for multinational companies into the Chinese market
SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- Opening up is the hallmark of contemporaryChina. The China International Import Expo (CIIE) is poised to shape a link betweenChina and the global market. Scheduled from Nov 5 to 10, the 4th CIIE presented a total of 422 new products, technologies, and s...
Henlius Novel Anti PD-L1/TIGIT Bispecific Antibody Received Clinical Trial Approval in Australia
SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the filing of a clinical trial for HLX301, a Recombinant Humanized Anti-PDL1 and Anti-TIGIT Bispecific Antibody, in Patients with locally advanced or metastatic solid tumours has been approved by the ...
More cancer patients in Africa to benefit from advanced radiation therapy with Elekta Unity MR-Linac
STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCESS 2025 strategy, which includes giving more than 300 million people access to radiation therapy with...
Elekta: Interim report, May-October 2021/22
STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- The increasing need for investments in cancer care and radiotherapy across the globe supported a gradual market recovery during the quarter. Our orders grew with double digits, and despite the continued global supply chain challenges we secured good revenu...
Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi
BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant onSeptember 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through th...
Sartorius significantly expands activities in South Korea
SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- The life science company Sartorius is investing around270 million euros, some 300 million U.S. dollars, through the end of 2024 in expanding its activities inSouth Korea. In the country's biopharma hub Songdo in Incheon, the company plans to launch cell cul...
USANA Assists Philippine Basketball Association As Nutritional Partner
USANA Named The Official Nutritional Supplements of the PBA SALT LAKE CITY, Nov. 25, 2021 /PRNewswire/ -- As USANA, the Cellular Nutrition Company, looks to its 30th anniversary next spring, it continues to showcase and build its elite and diverse athletic partnerships. For more than two decades...
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2022
Added 19,066 New Subscribers in 2Q22 Revenues Up 9.8% YoY to RMB313.7 Million ($48.7 Million) Gross Profit Up 11.0% YoY to RMB267.5 Million ($41.5 Million) Operating Income Up 15.3% YoY to RMB160.5 Million ($24.9 Million) Non-GAAP Operating Income Up 14.1% YoY to RMB172.8 Million ($26.8 Mi...
iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products
* iX Biopharma will receive an initial US$9 million upfront payment * Eligible for up to US$239 million in development and sales milestone payments * Double digit royalties on future product sales of any licensed product SINGAPORE, Nov. 25, 2021 /PRNewswire/ -- iX Biopharma Ltd (SGX:42C), a ...
Kintor Pharma Receives IND Clearance by NMPA for KX-826's Pivotal Study to Treat Male Alopecia Patients
SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the IND application for the pivotal study (phase III stage) of p...
Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore
GAITHERSBURG, Md., Nov. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its submission to the Singapore Health Sciences Authority (HSA) for interim ...
Neurophth Therapeutics Strengthens Leadership Team with Appointment of Su Zhang as Chief Financial Officer
SHANGHAI and SAN DIEGO, Nov. 24, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of gene therapies, today announced the recent appointment ofSu Zhang, M.B.A., as the Chief Financial Officer (CF...
Week's Top Stories
Most Reposted
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 319 media titles]
2024-05-08 14:37Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 310 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 297 media titles]
2024-05-08 16:44Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
[Picked up by 285 media titles]
2024-05-09 11:00